Public offering

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Greenlane Holdings, Inc.

Retrieved on: 
Monday, September 30, 2019
Finance, Economy, Money, Initial public offering, Public offering

In April 2019, the Company held its initial public offering (IPO) in which it sold more than 6 million common shares at $17.00 per share.

Key Points: 
  • In April 2019, the Company held its initial public offering (IPO) in which it sold more than 6 million common shares at $17.00 per share.
  • Since the IPO, shares of Greenlane has traded as low as $5.39, a nearly 68% decline from the $17 per share IPO price.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ProPetro Holding Corp.

Retrieved on: 
Monday, September 30, 2019
Initial public offering, Finance, Economy, Money, Public offering, Limited liability partnership

In March 2017, the Company completed its initial public offering, in which it sold 25 million shares of common stock at $14.00 per share.

Key Points: 
  • In March 2017, the Company completed its initial public offering, in which it sold 25 million shares of common stock at $14.00 per share.
  • The Form 8-K also stated that approximately $370,000 had been improperly reimbursed to members of senior management since the IPO.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Global Ship Lease, Inc. Announces Upsizing and Pricing of Public Offering of Class A Common Shares

Retrieved on: 
Friday, September 27, 2019
Finance, Initial public offering, Economy, Money, Corporate finance, Stock market, Public offering

LONDON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (Global Ship Lease or the Company) announced today that it has upsized and priced its previously announced fully underwritten public offering (the Offering) of $40.0 million Class A common shares, par value $0.01 per share (Common Shares).

Key Points: 
  • LONDON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (Global Ship Lease or the Company) announced today that it has upsized and priced its previously announced fully underwritten public offering (the Offering) of $40.0 million Class A common shares, par value $0.01 per share (Common Shares).
  • The Company has agreed to sell 6,620,686 Class A common shares, at $7.25 per share, for gross proceeds to the Company of approximately $48.0 million.
  • The Company also granted the underwriter a 30-day option to purchase up to an additional 993,102 Common Shares at the public offering price.
  • As part of the offering, the Companys executive management has agreed to purchase 168,965 Common Shares at the public offering price, representing an aggregate purchase price of approximately $1.225 million.

Forestar Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares

Retrieved on: 
Thursday, September 26, 2019
Construction & Property, Residential Building & Real Estate, Finance, Money, Financial markets, Corporate finance, Initial public offering, Stock market, Actuarial science, Underwriting, Forestar Group, Citigroup, Stock, Public offering

Forestar Group Inc. (NYSE: FOR) (Forestar) announced today that the underwriters for its previously announced public offering have exercised in full their option to purchase an additional 787,500 shares of Forestars common stock.

Key Points: 
  • Forestar Group Inc. (NYSE: FOR) (Forestar) announced today that the underwriters for its previously announced public offering have exercised in full their option to purchase an additional 787,500 shares of Forestars common stock.
  • The additional shares will be offered at a price to the public of $17.50 per share.
  • Total gross proceeds from this offering, including the underwriters option to purchase additional shares, are expected to be approximately $105.7 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Forestar.
  • Citigroup and J.P. Morgan are joint book-running managers and representatives of the underwriters for this offering.

Vaxart Announces Pricing of $8 Million Underwritten Public Offering

Retrieved on: 
Thursday, September 26, 2019
Finance, Money, Corporate finance, Initial public offering, Stock market, Equity securities, Financial markets, Prospectus, Stock, Public offering, Warrant, Security

In addition, Vaxart has granted the underwriters a 30-day option to purchase up to an additional 4,000,000 shares of common stock and/or common warrants to purchase up to 4,000,000 shares of common stock, at the public offering price, less discounts and commissions.

Key Points: 
  • In addition, Vaxart has granted the underwriters a 30-day option to purchase up to an additional 4,000,000 shares of common stock and/or common warrants to purchase up to 4,000,000 shares of common stock, at the public offering price, less discounts and commissions.
  • All of the securities to be sold in the offering are being offered by Vaxart.
  • The offering is expected to close on or about September 30, 2019, subject to customary closing conditions.
  • The offering was made only by means of a prospectus forming part of the effective registration statement.

BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Thursday, September 26, 2019
Finance, Money, Financial markets, Corporate finance, Initial public offering, Stock market, BTI, Public offering, Stock, Underwriting

NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or the Company)(Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced the pricing of an underwritten public offering of 2,303,030 shares of common stock at a public offering price of $8.25 per share.

Key Points: 
  • NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or the Company)(Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced the pricing of an underwritten public offering of 2,303,030 shares of common stock at a public offering price of $8.25 per share.
  • In addition, BTI has granted the underwriters a 30-day option to purchase up to an additional 345,454 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • All of the shares of common stock in the offering are being sold by BTI.
  • BMO Capital Markets Corp. is acting as book-running manager for the offering.

VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Thursday, September 26, 2019
Biotechnology, FDA, Health, Other Health, Pharmaceutical, Oncology, Research, Infectious diseases, Science, Clinical trials, Finance, Initial public offering, Money, Economy, Corporate finance, Stock market, Public offering, Underwriting, Greenshoe

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the closing of its previously announced underwritten public offering and the exercise in full of the underwriters option to purchase additional shares.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the closing of its previously announced underwritten public offering and the exercise in full of the underwriters option to purchase additional shares.
  • The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by VBI, are US$40.3 million.
  • 80,500,000 common shares at a public offering price of US$0.50 per share were issued and sold in this offering, which includes 10,500,000 shares issued upon the exercise of the underwriters option to purchase additional shares.
  • Immediately following the closing of the underwritten public offering, the number of outstanding common shares of the Company is 178,257,199.

Plymouth Industrial REIT Announces Pricing of Follow-On Offering of 3,000,000 Shares of Common Stock

Retrieved on: 
Thursday, September 26, 2019
Construction & Property, REIT, Finance, Initial public offering, Money, Economy, Corporate finance, Underwriting, Public offering, Real estate investment trust, Construction & Property, REIT, Finance, Initial public offering, Money, Economy, Corporate finance, Underwriting, Public offering, Real estate investment trust

Plymouth Industrial REIT, Inc. (NYSE American: PLYM) (the Company) today announced the pricing of its underwritten registered public offering of 3,000,000 shares of its common stock at a public offering price of $18.00 per share.

Key Points: 
  • Plymouth Industrial REIT, Inc. (NYSE American: PLYM) (the Company) today announced the pricing of its underwritten registered public offering of 3,000,000 shares of its common stock at a public offering price of $18.00 per share.
  • The Company granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of its common stock.
  • The offering is expected to close on September 30, 2019, subject to the satisfaction of certain customary closing conditions.
  • Net proceeds of the offering to the Company are expected to be approximately $51 million, after deducting underwriting commissions and offering expenses payable by the Company.

Forestar Prices Public Offering of Common Stock

Retrieved on: 
Thursday, September 26, 2019
Construction & Property, Residential Building & Real Estate, Finance, Money, Economy, Initial public offering, Stock market, Corporate finance, Forestar Group, Underwriting, Public offering, Mizuho Securities, Security, Wells Fargo

Forestar Group Inc. (NYSE: FOR) (Forestar) announced today the pricing of an underwritten public offering of 5,250,000 shares of its common stock, offered at a price to the public of $17.50 per share.

Key Points: 
  • Forestar Group Inc. (NYSE: FOR) (Forestar) announced today the pricing of an underwritten public offering of 5,250,000 shares of its common stock, offered at a price to the public of $17.50 per share.
  • The gross proceeds from this offering to Forestar are expected to be approximately $91.9 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Forestar.
  • Forestar has granted the underwriters a 30-day option to purchase up to an additional 787,500 shares of its common stock.
  • Mizuho Securities, Wells Fargo Securities and TD Securities are also acting as joint book-running managers for the offering.

BioXcel Therapeutics Announces Proposed Public Offering of Common Stock

Retrieved on: 
Wednesday, September 25, 2019
Finance, Money, Initial public offering, Economy, Corporate finance, ThinkEquity, BTI, Offering, Public offering

NEW HAVEN, Conn., Sept. 25, 2019 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or the Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced that it has commenced an underwritten public offering of $19.0 million of shares of its common stock.

Key Points: 
  • NEW HAVEN, Conn., Sept. 25, 2019 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or the Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced that it has commenced an underwritten public offering of $19.0 million of shares of its common stock.
  • In connection with the offering, BTI intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in the public offering.
  • ThinkEquity, a division of Fordham Financial Management, Inc., is acting as co-manager for the offering.
  • The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.